Rached Alkallas

618 total citations
6 papers, 138 citations indexed

About

Rached Alkallas is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rached Alkallas has authored 6 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Rached Alkallas's work include Melanoma and MAPK Pathways (3 papers), RNA modifications and cancer (2 papers) and Immunotherapy and Immune Responses (2 papers). Rached Alkallas is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), RNA modifications and cancer (2 papers) and Immunotherapy and Immune Responses (2 papers). Rached Alkallas collaborates with scholars based in Canada, United States and Israel. Rached Alkallas's co-authors include Hamed S. Najafabadi, Lisa Fish, Hani Goodarzi, Ian R. Watson, Mathieu Lajoie, Jonathan H. Zippin, Alan Spatz, Dan Moldoveanu, Philippe Lefrançois and Kevin Watters and has published in prestigious journals such as Nature Communications, Cell Reports and BMC Cancer.

In The Last Decade

Rached Alkallas

6 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rached Alkallas Canada	6	109	26	24	14	12	6	138
Roger Mulet‐Lazaro Netherlands	8	165 1.5×	12 0.5×	19 0.8×	13 0.9×	9 0.8×	18	219
Chuchu Wang China	9	123 1.1×	19 0.7×	18 0.8×	17 1.2×	4 0.3×	28	253
Lijun Yao United States	5	95 0.9×	24 0.9×	41 1.7×	9 0.6×	9 0.8×	14	160
Zhigang Zhao China	6	77 0.7×	16 0.6×	18 0.8×	9 0.6×	17 1.4×	10	133
Aditya Chandru United Kingdom	6	259 2.4×	39 1.5×	16 0.7×	16 1.1×	15 1.3×	6	306
María Sánchez‐Osuna Spain	8	115 1.1×	26 1.0×	17 0.7×	23 1.6×	12 1.0×	9	161
Priya Dalvi Germany	7	122 1.1×	31 1.2×	29 1.2×	20 1.4×	6 0.5×	10	166
Chongyin Han China	9	111 1.0×	18 0.7×	10 0.4×	24 1.7×	18 1.5×	14	168
Levi van Hijfte Netherlands	3	96 0.9×	22 0.8×	33 1.4×	20 1.4×	6 0.5×	7	147
Ilya Kovalenko Germany	4	120 1.1×	24 0.9×	34 1.4×	16 1.1×	14 1.2×	6	160

Countries citing papers authored by Rached Alkallas

Since Specialization

Citations

This map shows the geographic impact of Rached Alkallas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rached Alkallas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rached Alkallas more than expected).

Fields of papers citing papers by Rached Alkallas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rached Alkallas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rached Alkallas. The network helps show where Rached Alkallas may publish in the future.

Co-authorship network of co-authors of Rached Alkallas

This figure shows the co-authorship network connecting the top 25 collaborators of Rached Alkallas. A scholar is included among the top collaborators of Rached Alkallas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rached Alkallas. Rached Alkallas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Rajkumar, Shivshankari, LeeAnn Ramsay, Mathieu Lajoie, et al.. (2022). Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy. Cell Reports. 39(1). 110634–110634. 16 indexed citations

2.

Perron, Gabrielle, Pouria Jandaghi, Elham Moslemi, et al.. (2022). Pan-cancer analysis of mRNA stability for decoding tumour post-transcriptional programs. Communications Biology. 5(1). 851–851. 9 indexed citations

3.

Karachaliou, Georgia Sofia, Rached Alkallas, Nirali M. Patel, et al.. (2022). The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma. BMC Cancer. 22(1). 38–38. 5 indexed citations

4.

Dróżdż, M., Ashley S. Doane, Rached Alkallas, et al.. (2022). A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation. Cell Reports. 40(13). 111412–111412. 6 indexed citations

5.

Alkallas, Rached, Mathieu Lajoie, Dan Moldoveanu, et al.. (2020). Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma. Nature Cancer. 1(6). 635–652. 27 indexed citations

6.

Alkallas, Rached, Lisa Fish, Hani Goodarzi, & Hamed S. Najafabadi. (2017). Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer’s disease. Nature Communications. 8(1). 909–909. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact